FDA recall D-0145-2024

Bayer Healthcare Pharmaceuticals Inc. · Class I · drug

Product

VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01

Reason for recall

Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing

Distribution

Product was distributed to specialty pharmacies and distributors nationwide who may have further distributed the product.

Key facts

Status
Terminated
Initiation date
2023-11-06
Report date
2023-12-06
Termination date
2024-05-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Whippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0145-2024